Preformed anti-human leukocyte antigen antibodies jeopardize cardiac transplantation in patients with a left ventricular assist device

Heart and Lung: Journal of Acute and Critical Care

Volumn 31, Issue 2, 2002, Pages 122-132

  Goffinet, Jo ^a   Schneider, Barbara St Pierre ^b  

^a University of Wisconsin Health   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN; LEUKOCYTE ANTIGEN; OKT 3; SANDOBULIN; THYMOCYTE ANTIBODY;

ABSCESS; ADULT; ANTIBODY PRODUCTION; ARTICLE; ASSISTED CIRCULATION; CASE REPORT; COMPLEMENT DEPENDENT CYTOTOXICITY; EDUCATION; EMOTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; INFECTION; MALE; PLASMAPHERESIS; POSTOPERATIVE HEMORRHAGE; PREVALENCE; PRIORITY JOURNAL; SEPTICEMIA; THROMBOEMBOLISM; UNITED STATES;

EID: 0036213734     PISSN: 01479563     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhl.2002.122893     Document Type: Article

References (30)

1. Mechanical cardiac support 2000: Current applications and future trial design
2. HeartMate left ventricular assist device as a bridge to heart transplantation
3. Lymphocytes and lymphoid tissues
4. Immunoglobulins and immunoglobulin genes
5. Cytokines
6. Antigen presentation and the major histocompatibility complex
7. Immunologic consequences of blood transfusion and their clinical manifestations
8. Platelet transfusions are associated with the development of anti-major histocompatibility in patients with left ventricular assist support
9. Detection of anti-HLA antibody by flow cytometry in patients with a left ventricular assist device is associated with early rejection following heart transplantation
10. Detection of alloantibodies by flow cytometry: Relevance to clinical transplantation
11. Histocompatibility testing
12. Anti-HLA antibodies after solid organ transplantation
13. Antigenic specificity of antibody reactive in the antiglobulin-augmented lymphocytotoxicity test
14. Can anti-HLA antibody analyses postcardiac transplantation predict acute allograft rejection and survival?
15. The clinical significance of flow cytometry cross-matching in heart transplantation
16. Immunobiology of left ventricular assist devices
17. Factors influencing HLA sensitization in implantable LVAD recipients
18. Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation
19. Positive panel reactive antibody titers in patients bridged to transplantation with a mechanical assist device
20. Leukocyte depletion of the blood supply - How will patients benefit?
21. DRUGDEX system
22. Overview of transplantation immunology and the pharmacotherapy of adult solid organ transplant recipients: Focus on immunosuppression
23. Immunosuppression in transplantation
24. Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients
25. Immunosuppressive therapy
26. Leukocyte reduction of cellular blood components
27. Leukocyte depletion of random single-donor platelet transfusion does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: A randomized prospective study